Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

pancreatic cancer

  • You have access
    C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer
    YUKI FUJIWARA, KOICHIRO HARUKI, HIROAKI SHIBA, RYOGA HAMURA, TAKASHI HORIUCHI, YOSHIHIRO SHIRAI, KENEI FURUKAWA, TAKESHI GOCHO and KATSUHIKO YANAGA
    Anticancer Research November 2018, 38 (11) 6491-6499; DOI: https://doi.org/10.21873/anticanres.13013
  • You have access
    The Potential Use of a Ketogenic Diet in Pancreatobiliary Cancer Patients After Pancreatectomy
    JU HYE OK, HOSUN LEE, HAE-YUN CHUNG, SUNG HWAN LEE, EUN JEONG CHOI, CHANG MOO KANG and SONG MI LEE
    Anticancer Research November 2018, 38 (11) 6519-6527; DOI: https://doi.org/10.21873/anticanres.13017
  • You have access
    Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer
    HIROMICHI KAWAIDA, HIROSHI KONO, HIDETAKE AMEMIYA, RYOU SAITOU, ATSUSHI YAMAMOTO, NAOHIRO HOSOMURA, MITSUAKI WATANABE, AYAKO KIMURA, SHINJI FURUYA, HIROKI SHIMIZU, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, JUN ITAKURA, HIROSHI HAYAKAWA, HIROKO SHINDO, EI TAKAHASHI, SHINICHI TAKANO, MITSUHARU FUKASAWA, SHINTARO ICHIKAWA, HIDEKI FUJII and DAISUKE ICHIKAWA
    Anticancer Research November 2018, 38 (11) 6537-6542; DOI: https://doi.org/10.21873/anticanres.13019
  • You have access
    CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells
    KEISUKE KUHARA, KAZUHIRO TOKUDA, TAKAO KITAGAWA, BYRON BARON, MASAYUKI TOKUNAGA, KOJI HARADA, MASARU TERASAKI, OSAMU UEHARA, TOHRU OHTA, RIE TAKAI, JUN-ICHI HAMADA, MASANOBU KOBAYASHI, TSUYOSHI SHIMO, HIROKI NAGAYASU and YASUHIRO KURAMITSU
    Anticancer Research November 2018, 38 (11) 6107-6111; DOI: https://doi.org/10.21873/anticanres.12961
  • You have access
    Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells
    SHENGLING FU and JIAYUH LIN
    Anticancer Research November 2018, 38 (11) 6271-6279; DOI: https://doi.org/10.21873/anticanres.12983
  • You have access
    Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer
    MARIJA GER, ALGIRDAS KAUPINIS, MARIUS PETRULIONIS, BENEDIKTAS KURLINKUS, JONAS CICENAS, AUDRIUS SILEIKIS, MINDAUGAS VALIUS and KESTUTIS STRUPAS
    Anticancer Research October 2018, 38 (10) 5759-5765; DOI: https://doi.org/10.21873/anticanres.12914
  • You have access
    4-Methylumbelliferone Decreases the Hyaluronan-rich Extracellular Matrix and Increases the Effectiveness of 5-Fluorouracil
    ERI YOSHIDA, DAISUKE KUDO, HAYATO NAGASE, AKIKO SUTO, HIROSHI SHIMODA, SHINICHIRO SUTO, IKUKO KAKIZAKI, MASAHIKO ENDO and KENICHI HAKAMADA
    Anticancer Research October 2018, 38 (10) 5799-5804; DOI: https://doi.org/10.21873/anticanres.12919
  • You have access
    Relationship Between CA 19.9 and the Lewis Phenotype: Options to Improve Diagnostic Efficiency
    MARINA PARRA-ROBERT, VÍCTOR MOLINA SANTOS, SILVIA MIRÓ CANIS, XAVIER FILELLA PLA, JOSEP MARIA AUGÉ FRADERA and RAFAEL MOLINA PORTO
    Anticancer Research October 2018, 38 (10) 5883-5888; DOI: https://doi.org/10.21873/anticanres.12931
  • You have access
    Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas
    ROSA B. SCHMUCK, CHRISTIAN BROKAT, ANDREAS ANDREOU, MATTHÄUS FELSENSTEIN, FRITZ KLEIN, BRUNO SINN, JOHANN PRATSCHKE and MARCUS BAHRA
    Anticancer Research September 2018, 38 (9) 5379-5386; DOI: https://doi.org/10.21873/anticanres.12867
  • You have access
    Morphological Analysis of Amoeboid–Mesenchymal Transition Plasticity After Low and High LET Radiation on Migrating and Invading Pancreatic Cancer Cells
    ANGELICA FACOETTI, CARMELA DI GIOIA, FRANCESCA PASI, RICCARDO DI LIBERTO, FRANCO CORBELLA, ROSANNA NANO, MARIO CIOCCA, FRANCESCA VALVO and ROBERTO ORECCHIA
    Anticancer Research August 2018, 38 (8) 4585-4591; DOI: https://doi.org/10.21873/anticanres.12763

Pages

  • Previous
  • Next
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 25
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire